Synaptic vesicle endocytosis deficits underlie cognitive dysfunction in mouse models of GBA-linked Parkinson’s disease and dementia with Lewy bodies
GBA is the major risk gene for Parkinson's disease (PD) and dementia with Lewy bodies (DLB), two common α-synucleinopathies with cognitive deficits. Here we investigate the role of mutant GBA in cognitive decline by utilizing Gba (L444P) mutant, SNCA transgenic (tg), and Gba-SNCA double mutant mice. Notably, Gba mutant mice show cognitive decline but lack PD-like motor deficits or α-synuclein pathology. Conversely, SNCA tg mice display age-related motor deficits, without cognitive abnormalities. Gba-SNCA mice exhibit both cognitive decline and exacerbated motor deficits, accompanied by greater cortical phospho-α-synuclein pathology, especially in layer 5 neurons. Single-nucleus RNA sequencing of the cortex uncovered synaptic vesicle (SV) endocytosis pathway defects in excitatory neurons of Gba mutant and Gba-SNCA mice, via downregulation of genes regulating SV cycle and synapse assembly. Immunohistochemistry and electron microscopy validate these findings. Our results indicate that Gba mutations, while exacerbating pre-existing α-synuclein aggregation and PD-like motor deficits, contribute to cognitive deficits through α-synuclein-independent mechanisms, involving dysfunction in SV endocytosis.
Authors
- David Bäckström (ORCID: https://orcid.org/0000-0002-4417-2475)
- Jiapeng Ruan (ORCID: https://orcid.org/0000-0001-7569-7031)
- Rajarshi Chakraborty (ORCID: https://orcid.org/0000-0003-2304-2177)
- D. J. Vidyadhara (ORCID: https://orcid.org/0000-0003-0974-0307)
- Pramod K. Mistry (ORCID: https://orcid.org/0000-0003-3447-6421)
- Sreeganga S. Chandra (ORCID: https://orcid.org/0000-0001-9035-1733)
- Jae-Min Park (ORCID: https://orcid.org/0000-0002-9770-7197)
Institutions
- Van Andel Institute (US)
- Rosalind Franklin University of Medicine and Science (US)
- Yale University (US)
- Umeå University (SE)
Publication Details
- Journal
- Nature Communications
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1038/s41467-025-63444-9
- Citations
- 4
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 5.56